Arkolith/Insider Trading/BCRX/Form 4

Gayer Charles K

President and CCOBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed Dec 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2025Option exercise(M)10K$5.04$51K903K
Dec 22, 2025Option exercise(M)14K$3.22$46K892K
Dec 22, 2025Option exercise(M)50K$5.51$276K953K
Dec 19, 2025Tax withholding(F)11K$7.41$85K878K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2025Option exercise(M)14K—$00
Dec 22, 2025Option exercise(M)10K—$017K
Dec 22, 2025Option exercise(M)50K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000882796-25-000041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML